https://www.pharmaceutical-technology.com/data-insights/axitinib-sr-alcon-wet-neovascular-exudative-macular-degeneration-likelihood-of-approval/
Axitinib SR is under clinical development by Alcon and currently in Phase II for Wet (Neovascular / Exudative) Macular Degeneration.
macular degenerationaxitinibsralconwet
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-axitinib-advanced-bowel-cancer-axmus-c
This trial is looking at axitinib to treat bowel cancer that has spread to another part of the body (advanced bowel cancer).
advanced bowel cancertriallookingaxitinib